GlassScriptPhysician profile
Paul A Rollins
NPI 1407840762
$7,625.24
in general payments reported to CMS, 2019-2025
14 companies · $1,493 in 2025
The $1,493 reported for 2025 was more than what 79% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $246 · 2021: $1,965 · 2022: $2,035 · 2023: $1,170 · 2024: $578 · 2025: $1,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922 · Travel and Lodging: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.85 |
| Travel and Lodging | $1,318.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $6,305.25 | 2019-2025 | |
| Integra Lifesciences Corporation | $461.74 | 2020-2022 | |
| Mentor Worldwide LLC | $276.87 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Depuy Synthes Sales INC. | $166.59 | 2019-2024 | Xcm Biologic Tissue Matrix, Matrixmandible |
| Smith+Nephew, INC. | $102.79 | 2019-2025 | Collagenase Santyl, Stravix |
| Medical Device Business Services, INC. | $94.50 | 2024 | Xcm Biologic Tissue Matrix |
| Becton, Dickinson and Company | $41.02 | 2025 | Surgiphor |
| Misonix INC | $35.15 | 2021 | |
| Abbvie INC. | $34.98 | 2023-2025 | |
| Innovation Technologies INC | $33.34 | 2022 | |
| Allergan, INC. | $22.94 | 2019-2021 | |
| Eisai INC. | $21.57 | 2019 | |
| Reddress USA, INC. | $16.80 | 2022 | |
| Axogen | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Rollins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.